CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Weinberg Uri Chief Science Officer | Sale | −1,946 | $120.00 | $234K | 47,104 |
| 2023-01-05 | Weinberg Uri Chief Science Officer | Sale | −2,617 | $108.00 | $283K | 44,487 |
| 2023-01-05 | Weinberg Uri Chief Science Officer | Sale | −1,201 | $120.00 | $144K | 43,286 |
| 2023-01-05 | Weinberg Uri Chief Science Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,946 | 1,946 | ||
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −2,345 | $119.01 | $279K | 48,111 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −417 | $108.00 | $45K | 47,694 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −526 | $115.03 | $61K | 47,168 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −1,010 | $117.00 | $118K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion | +7,826 | $14.37 | $112K | 53,984 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −7,826 | $108.00 | $845K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion | +7,500 | $11.46 | $86K | 53,658 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −7,500 | $108.00 | $810K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion | +5,517 | $7.15 | $39K | 51,675 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −5,517 | $108.00 | $596K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion | +7,183 | $21.15 | $152K | 53,341 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −7,183 | $114.00 | $819K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion | +7,183 | $21.15 | $152K | 53,341 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Sale | −7,183 | $120.00 | $862K | 46,158 |
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion · Options to Buy Ordinary Shares | −7,826 | 0 | ||
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion · Options to Buy Ordinary Shares | −7,500 | 0 |
Page 17 of 20 · 399 trades